1.20
1.20 (0%)
As of Feb 14, 2025
Neuroone Medical Technologies Corp [NMTC]
Source:
Company Overview
Weare a medical technology company focused on the development and commercialization of thin film electrode technology for continuous electroencephalogram(cEEG) and stereoelectrocencephalography (sEEG), spinal cord stimulation, brain stimulation and ablation solutions for patients sufferingfrom epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurologicaldisorders.
| Country | United States |
| Headquarters | eden prairie, minnesota |
| Phone Number | (952) 426-1383 |
| Industry | manufacturing |
| CEO | David Rosa |
| Website | www.n1mtc.com. |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0.8 |
| Operating Profit | $-2.8 |
| Net Income | $-2.8 |
| Net Cash | $-3.7 |
Profit Ratios
| Gross Margin | $0.3 |
| Operating Margin | -338.3 |
| Profit as % of Revenues | -10.2% |
| Profit as % of Assets | -96.5% |
| Profit as % of Stockholder Equity | -91.9% |
Management Effectiveness
| Return on Equity | -91.9% |
| Return on Assets | -56.3% |
| Turnover Ratio | 28.8% |
| EBITA | $-2.8 |
Balance Sheet and Cash Flow Measures
| Total Assets | $4.9 |
| Total Liabilities | $1.9 |
| Operating Cash Flow | $-8.3 |
| Investing Cash Flow | $-0.1 |
| Financing Cash Flow | $4.7 |
